⚠️ Note: LiquidGlassView requires Xcode 26.0+ and iOS 26+ for full glass effects. The component automatically falls back to enhanced blur on older versions.
Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results